Contact this trialFirst, we need to learn more about you.
Gene Therapy
Gene Therapy for Age-Related Macular Degeneration
Recruiting1 awardPhase 1
Dallas, Texas
This trial is testing a new gene therapy called KH631 for patients with a severe eye condition known as neovascular AMD. The therapy uses a harmless virus to deliver a protein that blocks a harmful substance in the eye. This could help improve vision and reduce the need for frequent eye injections.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service